Farxiga Approved to Reduce Risk for CKD Progression
SGLT2 inhibitor approved for patients with CKD to prevent kidney function decline, kidney failure, CV death, hospitalization for heart failure
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.